Mevox
PrivateLast Round
Series A
Feb 11, 2021
Total Funding Raised
$6.08M
Company Overview
Mevox operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in February 2021.
Mevox is a pharmaceuticals and biotechnology company that develops optimized protein vaccines designed to induce higher antibody levels.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mevox Comparables
Compare Mevox with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Baseimmune | 79% | |
| Lovaltech | 77% | |
| SpyBiotech | 75% |
For institutional investors. Book with your work email.
Mevox Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mevox Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2021
$6M round led by Morningside Ventures.
For institutional investors. Book with your work email.
Mevox Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mevox's valuation, stock price, and market status.
Is Mevox a public or private company?
Mevox is a private company.
What is the current stock price of Mevox?
Mevox is a private company, so its shares have no public market price. Caplight tracks Mevox's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mevox worth (valuation)?
Valuation information for Mevox is not publicly available.
Can I buy Mevox stock?
Mevox shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mevox's last funding round?
Mevox's most recent funding round was Series A on February 11, 2021.
Who are the main investors in Mevox?
Key investors in Mevox include Morningside Ventures.
Will Mevox IPO soon?
No public IPO plans have been announced for Mevox.
How can I track Mevox secondary market activity?
Caplight tracks bids, offers, and trades in Mevox's shares on secondary markets.